Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of Invention Described in U.S. Provisional Patent Application Concerning Treatment of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin Complexes, 9103 [E8-2980]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices
DEPARTMENT OF DEFENSE
DEPARTMENT OF DEFENSE
Department of the Army
Department of the Army; Corps of
Engineers
Availability for Non-Exclusive,
Exclusive, or Partially Exclusive
Licensing of Invention Described in
U.S. Provisional Patent Application
Concerning Treatment of IschemiaReperfusion Injury with Lipid, Annexin,
and Lipid-Annexin Complexes
AGENCY:
ACTION:
Department of the Army, DoD.
Notice.
SUMMARY: In accordance with 37 CFR
404.4, 404.6 and 404.7, announcement
is made of the availability for licensing
of the invention described in U.S.
Provisional Patent Application No. 60/
786,527 entitled ‘‘Treatment of
Ischemia-Reperfusion Injury with Lipid,
Annexin, and Lipid-Annexin
Complexes,’’ filed March 27, 2006.
Foreign rights are also available (PCT/
US2007/065125). The United States
Government, as represented by the
Secretary of the Army, has rights in this
invention.
Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–ZA–J, 504 Scott
Street, Fort Detrick, Frederick, MD
21702–5012.
ADDRESSES:
For
patent issues, Ms. Elizabeth Arwine,
Patent Attorney, (301) 619–7808. For
licensing issues, Dr. Paul Mele, Office of
Research & Technology Assessment,
(301) 619–6664, both at telefax (301)
619–5034.
FOR FURTHER INFORMATION CONTACT:
Disclosed
are lipids, annexin, and lipid-annexin
complexes for use in the prevention
and/or treatment of ischemiareperfusion injury and reperfusion
injury associated with a variety of
diseases and conditions. Also disclosed
are therapeutic targets and compositions
for the prevention and treatment of
ischemia-reperfusion injury and
diseases and conditions associated with
ischemia-reperfusion injury.
SUPPLEMENTARY INFORMATION:
mstockstill on PROD1PC66 with NOTICES
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E8–2980 Filed 2–15–08; 8:45 am]
BILLING CODE 3710–08–P
VerDate Aug<31>2005
16:52 Feb 15, 2008
Jkt 214001
Notice of Intent To Prepare a Draft
Environmental Impact Statement on
Rock Mining in Wetlands in Levy
County, FL
Department of the Army, U.S.
Army Corps of Engineers, DoD.
ACTION: Notice of intent.
AGENCY:
SUMMARY: The U.S. Army Corps of
Engineers (Corps) Jacksonville District
intends to prepare a Draft
Environmental Impact Statement (DEIS),
referred to as the Tarmac King Road
Limestone Mine DEIS, to evaluate
potential impacts of rock mining within
wetlands in southern Levy County, FL.
DATES: The Corps plans to hold two
public scoping meetings on or about
March 26 and 27, 2008 at 6 p.m. EST.
ADDRESSES: The first meeting will be
held on March 26, 2008 at the Inglis
Community Center, 137 Highway 40
West, Inglis, FL 34449, (352) 447–2203.
The second meeting will be held March
27, 2008 at the Tommy Usher
Community Center, 506 Southwest 4th
Avenue, Chiefland, FL 32626–0121,
(352) 493–6711.
FOR FURTHER INFORMATION CONTACT: Mr.
Edward P. Sarfert, (850) 439–9533 or
e-mail at
edward.p.sarfert@usace.army.mil.
SUPPLEMENTARY INFORMATION:
a. Background/Project Authorization.
The Corps is preparing this DEIS in
accordance with the National
Environmental Policy Act (NEPA) of
1969 (42 U.S.C. 4321 et seq.), Council of
on Environmental Quality (CEQ)
Regulations (40 CFR 1500 et seq.), and
Corps provisions for implementing the
procedural requirements of NEPA (33
CFR 230, USACE Engineering
Regulation ER 200–2–2). A primary
purpose of a Corps Regulatory Program
EIS is to provide full and fair discussion
of the significant environmental impacts
of a proposal or project seeking a U.S.
Department of Army permit. The Draft
and Final EIS are used to inform the
public and agency decision-makers of
alternatives to an applicant’s project
that might avoid or minimize adverse
impacts or enhance the quality of the
human environment. An EIS is not a
Corps regulatory decision document. It
is used by agency officials in
conjunction with other relevant
information in a permit application file,
including public and agency comments
presented in the Final EIS, to support
the final decision on a permit
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
9103
application. In this instance, Tarmac
America, LLC, has filed a permit
application to mine areas that include
wetlands within Levy County, FL.
b. Need or Purpose. The purpose of
the proposed action is to provide
construction-grade aggregate that meets
the Florida Department of
Transportation specifications for
buildings and infrastructure. The
proposed mine is to provide this
aggregate for Tarmac’s and its
customers’ use in the west central area
of Florida. The Corps recognizes that
there is a public and private need for
this product. The purpose of the
proposed DEIS is to evaluate the
environmental effects of alternatives to
meet these requirements while
protecting the aquatic environment.
c. Prior EAs, EISs. None.
d. Alternatives. An evaluation of
alternatives, including a No Action
alternative and rock mining in other
areas both inside and outside of Levy
County and/or Florida will be done. The
DEIS will analyze reasonable
alternatives to obtaining construction
grade limestone to meet the purpose and
need. Alternatives will be determined
through scoping, but are expected to
vary according to timing, and breadth of
mining, in addition to a ‘‘no action’’
alternative.
e. Issues. The following issues have
been identified for analysis in the DEIS.
This list is preliminary and is intended
to facilitate public comment on the
scope of the DEIS. The DEIS will
consider the effects on Federally listed
threatened and endangered species,
health and safety, socioeconomics,
aesthetics, general environmental
concerns, wetlands (and other aquatic
resources), historic properties, cultural
resources, fish and wildlife values, land
use, transportation, recreation, water
supply and conservation, water quality,
energy needs, mineral needs,
considerations of property ownership,
and, in general, the needs and welfare
of the people, and other issues
identified through scoping, public
involvement, and interagency
coordination. At the present time, our
primary areas of environmental concern
are the loss of wetland functions and
value, mitigation of such losses, and the
effect of proposed mining on
groundwater and surface water quality
and on transportation. We expect to
better define the issues of concern and
define the methods that will be used to
evaluate those issues through the
scoping process.
f. Scoping Process. CEQ regulations
(40 CFR 1501.7) require an early and
open process for determining the scope
of a DEIS and for identifying significant
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 73, Number 33 (Tuesday, February 19, 2008)]
[Notices]
[Page 9103]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-2980]
[[Page 9103]]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Availability for Non-Exclusive, Exclusive, or Partially Exclusive
Licensing of Invention Described in U.S. Provisional Patent Application
Concerning Treatment of Ischemia-Reperfusion Injury with Lipid,
Annexin, and Lipid-Annexin Complexes
AGENCY: Department of the Army, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with 37 CFR 404.4, 404.6 and 404.7, announcement
is made of the availability for licensing of the invention described in
U.S. Provisional Patent Application No. 60/786,527 entitled ``Treatment
of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin
Complexes,'' filed March 27, 2006. Foreign rights are also available
(PCT/US2007/065125). The United States Government, as represented by
the Secretary of the Army, has rights in this invention.
ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort
Detrick, Frederick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul
Mele, Office of Research & Technology Assessment, (301) 619-6664, both
at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION: Disclosed are lipids, annexin, and lipid-
annexin complexes for use in the prevention and/or treatment of
ischemia-reperfusion injury and reperfusion injury associated with a
variety of diseases and conditions. Also disclosed are therapeutic
targets and compositions for the prevention and treatment of ischemia-
reperfusion injury and diseases and conditions associated with
ischemia-reperfusion injury.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E8-2980 Filed 2-15-08; 8:45 am]
BILLING CODE 3710-08-P
